Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.34 |
| ▸ | HTR2A | P28223 | 2/20 | 0.34 |
| ▸ | HTR7 | P34969 | 2/20 | 0.34 |
| ▸ | HTR6 | P50406 | 2/20 | 0.34 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | HTR1B | P28222 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2430976 | 0.87 | KCNA3 (0.43) | KCNA3HRH3HTR2AHTR7HTR6 | |
| SCHEMBL30420586 | 0.85 | KCNA3 (0.36) | KCNA3HRH3HTR2AHTR7HTR6 | |
| SCHEMBL654398 | 0.84 | ALDH1A1 (0.44) | ADRA1DADRA1AADRA1BTDP1GAA | |
| SCHEMBL12290140 | 0.76 | MAPT (0.36) | KCNA3TDP1GAAL3MBTL1HTR1B | |
| SCHEMBL26071857 | 0.75 | L3MBTL1 (0.61) | KCNA3HRH3HTR2AHTR7HTR6 | |
| SCHEMBL10019289 | 0.74 | RIPK1 (0.37) | SLC6A4 | |
| SCHEMBL26376093 | 0.74 | L3MBTL1 (0.43) | KCNA3HRH3HTR2AHTR7HTR6 | |
| SCHEMBL29212120 | 0.74 | ALDH1A1 (0.41) | TDP1GAAL3MBTL1MEN1KMT2A | |
| SCHEMBL22163963 | 0.73 | ADRA1D (0.36) | ADRA1DADRA1AADRA1B | |
| SCHEMBL30267579 | 0.73 | HPGD (0.55) | TDP1GAAL3MBTL1CNR2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312765-A1 | COMPOUND COMPRISING AN EPOXIDE GROUP | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2023-10-05 | — | — | US | disclosed |
| CN-115916847-A | Grafted elastomers with pendant epoxy groups | 米其林集团总公司 | 2023-04-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312765-A1 | COMPOUND COMPRISING AN EPOXIDE GROUP | F12, EPHX2, C9 | KCNA3 644/4885HRH3 115/4885HTR2A 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.